Development of a nano-micro carrier system for sustained pulmonary delivery of clarithromycin

Powder Technology

Volumn 239, Issue , 2013, Pages 478-483

  Moghaddam, P Hadipour ^a   Ramezani, V ^a,b   Esfandi, E ^a   Vatanara, A ^a   Nabi Meibodi, M ^a,b   Darabi, M ^a   Gilani, K ^a   Najafabadi, A R ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Shahid Sadouqi University of Medical Science   (Iran)

Author keywords

Clarithromycin; Inhalation; L leucine; Nanoparticles; PLGA

Indexed keywords

CLARITHROMYCIN; EMULSIFICATION-SOLVENT EVAPORATIONS; INHALATION; L-LEUCINE; PHYSICOCHEMICAL CHARACTERISTICS; PLGA; POLY LACTIDE-CO-GLYCOLIDE; RESPIRATORY DRUG DELIVERIES;

AERODYNAMICS; AMINO ACIDS; COPOLYMERS; DRUG DELIVERY; EMULSIFICATION; SPRAY DRYING; THERMOANALYSIS;

NANOPARTICLES;

CLARITHROMYCIN; LACTOSE; MANNITOL; NANOPARTICLE; POLYGLACTIN;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; FLOW RATE; FREEZE DRYING; MEDICAL DEVICE; MORPHOLOGY; NANOTECHNOLOGY; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; PROCESS DEVELOPMENT; RESPIRATORY SYSTEM; SCANNING ELECTRON MICROSCOPY; THERMAL ANALYSIS; THERMODYNAMICS;

EID: 84875523410     PISSN: 00325910     EISSN: 1873328X     Source Type: Journal    
DOI: 10.1016/j.powtec.2013.02.025     Document Type: Article

References (29)

1. Piscitelli S.C., Danziger L.H., Rodvold K.A. Clarithromycin and azithromycin: new macrolide antibiotics. Clinical Pharmacy 1992, 11:137-152.
2. Laurence Brunton J.L., Parker Keith Goodman and Gilman's the Pharmacological Basis of Therapeutics October 28, 2005, 11th edition.
3. Salem I.I., Düzgünes N. Efficacies of cyclodextrin-complexed and liposome-encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages. International Journal of Pharmaceutics 2003, 250:403-414.
4. Rodvold K.A. Clinical pharmacokinetics of clarithromycin. Clinical Pharmacokinetics 1999, 37:385-398.
5. Rau J.L. The inhalation of drugs: advantages and problems. Respiratory Care 2005, 50:367-382.
6. F. Zhou, F. Kong, L. Ge, X. Liu, N. Huang, Mannan-modified PLGA nanoparticles for targeted gene delivery, International Journal of Photoenergy 2012 (in press) (Article ID 926754).
7. Gupta H., Aqil M., Khar R.K., Ali A., Bhatnagar A., Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine: Nanotechnology, Biology and Medicine 2010, 6:324-333.
8. Dillen K., Vandervoort J., Van den Mooter G., Ludwig A. Evaluation of ciprofloxacin-loaded Eudragit® RS100 or RL100/PLGA nanoparticles. International Journal of Pharmaceutics 2006, 314:72-82.
9. Ji W., Yang F., Seyednejad H., Chen Z., Hennink W.E., Anderson J.M., van den Beucken J.J.J.P., Jansen J.A. Biocompatibility and degradation characteristics of PLGA-based electrospun nanofibrous scaffolds with nanoapatite incorporation. Biomaterials 2012, 33:6604-6614.
10. Mohammadi G., Nokhodchi A., Barzegar-Jalali M., Lotfipour F., Adibkia K., Ehyaei N., Valizadeh H. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system. Colloids and Surfaces. B, Biointerfaces 2011, 88:39-44.
11. Ramezani V., Vatanara A., Rouholamini Najafabadi A., Gilani K., Nabi-Meybodi M. Screening and evaluation of variables in the formation of antibody particles by spray drying. Powder Technology 2013, 233:341-346.
12. Prime D., Atkins P.J., Slater A., Sumby B. Review of dry powder inhalers. Advanced Drug Delivery Reviews 1997, 26:51-58.
13. Najafabadi A.R., Gilani K., Barghi M., Rafiee-Tehrani M. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with l-leucine. International Journal of Pharmaceutics 2004, 285:97-108.
14. Mainardes R.M., Evangelista R.C. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. International Journal of Pharmaceutics 2005, 290:137-144.
15. Budhian A., Siegel S.J., Winey K.I. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. International Journal of Pharmaceutics 2007, 336:367-375.
16. Song X., Zhao Y., Wu W., Bi Y., Cai Z., Chen Q., Li Y., Hou S. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency. International Journal of Pharmaceutics 2008, 350:320-329.
17. Song X., Zhao Y., Hou S., Xu F., Zhao R., He J., Cai Z., Li Y., Chen Q. Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. European Journal of Pharmaceutics and Biopharmaceutics 2008, 69:445-453.
18. Wang C., Ye W., Zheng Y., Liu X., Tong Z. Fabrication of drug-loaded biodegradable microcapsules for controlled release by combination of solvent evaporation and layer-by-layer self-assembly. International Journal of Pharmaceutics 2007, 338:165-173.
19. Corrigan O.I., Li X. Quantifying drug release from PLGA nanoparticulates. European Journal of Pharmaceutical Sciences 2009, 37:477-485.
20. Fonseca C., Simões S., Gaspar R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. Journal of Controlled Release 2002, 83:273-286.
21. Tripathi A., Gupta R., Saraf S.A. PLGA nanoparticles of anti tubercular drug: drug loading and release studies of a water in-soluble drug. International Journal of PharmTech Research 2010, 2:2116-2123.
22. Arpagaus C., Meuri M. Laboratory scale spray drying of inhalable particles: a review. Respiratory Drug Delivery 2010, 469-473.
23. Maury M., Murphy K., Kumar S., Shi L., Lee G. Effects of process variables on the powder yield of spray-dried trehalose on a laboratory spray-dryer. European Journal of Pharmaceutics and Biopharmaceutics 2005, 59:565-573.
24. Kho K., Hadinoto K. Effects of excipient formulation on the morphology and aqueous re-dispersibility of dry-powder silica nano-aggregates. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2010, 359:71-81.
25. Bull H.B., Breese K. Surface tension of amino acid solutions: a hydrophobicity scale of the amino acid residues. Archives of Biochemistry and Biophysics 1974, 161:665-670.
26. Sou T., Orlando L., McIntosh M.P., Kaminskas L.M., Morton D.A.V. Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: a design of experiment approach. International Journal of Pharmaceutics 2011, 421:220-229.
27. Chew N.Y.K., Tang P., Chan H.-K., Raper J.A. How much particle surface corrugation is sufficient to improve aerosol performance of powders?. Pharmaceutical Research 2005, 22:148-152.
28. Chew N.Y.K., Chan H.K. Use of solid corrugated particles to enhance powder aerosol performance. Pharmaceutical Research 2001, 18:1570-1577.
29. Feng A.L., Boraey M.A., Gwin M.A., Finlay P.R., Kuehl P.J., Vehring R. Mechanistic models facilitate efficient development of leucine containing microparticles for pulmonary drug delivery. International Journal of Pharmaceutics 2011, 409:156-163.